Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine, dexmedetomidine, and dizocine for cesarean section under combined spinal-epidural anesthesia
ChiCTR2000031377Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine, dexmedetomidine and dezocine in caesarean delivery (C-section) (5 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: visceral pain, shivering and 1 more. Started Apr 2020; status: recruiting.
02
Drugs
nalbuphinedexmedetomidinedezocine
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on ChiCTR2000031377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031377.